AGP Executive Report
Last update: 11 hours agoPatient Safety Day: Kuwait’s Ministry of Health marked World Patient Safety Day with “Safe Care for Life,” urging safer diagnosis, medication use, fewer errors, and better patient-team communication for people living with chronic diseases. Policy & Prevention: The U.S. USPSTF got a new chair and eight new members, with updated leadership meant to shape which preventive services insurers must cover. Tobacco Harm Reduction Under Scrutiny: A JAPhA-backed report says nicotine pouches may pose risks for youth initiation and dual use, even as they’re marketed as a cleaner alternative. New Cancer Care Data: SWOG S1602 results suggest the Tokyo-172 BCG strain can be noninferior to standard TICE BCG for high-risk bladder cancer, though with more severe side effects. Gene & Cell Therapy Advances: The FDA cleared a Phase 1b/2 CAR T-cell trial for progressive MS and approved UX111 gene therapy for pediatric Sanfilippo A; it also approved finerenone (Kerendia) for CKD tied to type 1 diabetes. Care Access & Workforce: OSF HealthCare added a pulmonary/critical care specialist in Illinois, while Piedmont announced a new lung transplant program in Georgia. Community Health Gaps: A Parkersburg RAP session brought together behavioral health and justice partners to reduce arrests and ER detours for people needing treatment. Wellness & Lifestyle: Resistance training was linked to “younger” brain-age estimates in older adults, and omega-3 intake showed an association with better survival in fatty liver disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.